Cure for Certain Cancers Is ‘Realistic’ Goal in Next Decade, Pharma Leader Says

The prospect of curing certain cancers within the next decade is becoming increasingly realistic, according to pharmaceutical leaders and medical experts.

Speaking at a recent summit, Johnson & Johnson CEO Joaquin Duato highlighted advances in immunotherapy that use a patient’s own immune system to fight cancer, noting that some patients with multiple myeloma who had exhausted other treatment options have remained in remission for more than five years after a single administration.

Experts also pointed to the growing role of biomarkers and artificial intelligence in enabling earlier diagnosis and more personalized treatment approaches—developments that could significantly shape the future of cancer care and population health outcomes. Read more from Fox News here.